Initial Public Offering. A biotechnology compury. Keros Therapeutics, completed its IPO on Apul 8, 20e0, and listed on the Nanday Keriss sald 6 oon, 000 shares of thek to primary market investors at an IPO offer price of $16.81, with an underwiting discount of 6.37. Secondary market investars, however, were porme I2025 per share ke Kerus? 19,189,391 shares of stock outstanding (which inchudes the newly -issued shares)" a. Calculate the total proceeds for Keros' IPO b. Calculate the dollar amount of the underwitang fee for Keros' IPO c. Cakculate the net proceeds for Keros' IPO. d. Calculate market capitalization for Keros' outstanding stock. e. Calculate IPO underpricing for Keros' IPO f. Explain the IPO underpricing for Keros